Although people often say they have strep throat, most sore throats actually are caused by a virus, not streptococcus bacteria, and shouldnt be treated with antibiotics, suggest guidelines published by the Infectious Diseases Society of America (IDSA). Antibiotics are ineffective against viruses.
The IDSAs newly revised guidelines for Group A streptococcal pharyngitis strep throat also advise that when a strep infection is confirmed by testing, it should be treated with penicillin or amoxicillin if the patient does not have an allergy and not an antibiotic such as a cephalosporin. Further, the guidelines recommend that children who suffer from recurrent strep throat should not have their tonsils surgically removed solely to reduce the frequency of infection. The guidelines are being published today in the journal Clinical Infectious Diseases.
About 15 million people in the U.S. see the doctor for a sore throat every year and up to 70 percent receive antibiotics, although only a smaller percentage actually have strep throat: approximately 20 to 30 percent of children and just 5 to 15 percent of adults.
The guidelines note that children and adults do not need to be tested for strep throat if they have a cough, runny nose, hoarseness and mouth sores, which are strong signs of a viral throat infection. A sore throat is more likely to be caused by strep if the pain comes on suddenly, swallowing hurts and the sufferer has a fever without the above features, but should be confirmed through testing before antibiotics are prescribed, the guidelines note.
If strep is suspected, the guidelines recommend physicians use the rapid antigen detection test, which provides results in a few minutes. If that test is negative, a follow-up throat culture is recommended for children and adolescents, but not for adults. Results of the culture can take up to several days, but antibiotics should not be prescribed unless results are positive, the guidelines note. Because strep throat is uncommon in children three years old or younger, they dont need to be tested, the guidelines recommend.
The guidelines promote accurate diagnosis and treatment, particularly in avoiding the inappropriate use of antibiotics, which contributes to drug-resistant bacteria, says lead author Stanford T. Shulman, MD, chief of the division of infectious diseases at Ann & Robert H. Lurie Childrens Hospital of Chicago and professor of pediatrics at Northwestern University Fineberg School of Medicine. We recommend penicillin or amoxicillin for treating strep because they are very effective and safe in those without penicillin allergy, and there is increasing resistance of strep to the broader-spectrum and more expensive macrolides, including azithromycin.
He notes the guidelines recommend against tonsillectomy for children with repeated throat infection except in very specific cases such as a child who has obstructive breathing because the risks of surgery are generally not worth the transient benefit.
Â
Serious complications from strep throat particularly rheumatic fever have diminished in the United States, but occasionally do occur, so accurate diagnosis is key, Shulman says.
The voluntary guidelines are not intended to take the place of a doctors judgment, but rather to support the decision-making process, which must be individualized according to each patients circumstances.
The eight-member Group A streptococcal pharyngitis guidelines panel comprises experts representing a variety of specialties, including adult and pediatric infectious diseases physicians, pediatricians and respiratory diseases authorities. In addition to Dr. Shulman, the panel includes: Alan L. Bisno, Herbert W. Clegg, Michael A. Gerber, Edward L. Kaplan, Grace Lee, Judith M. Martin and Chris Van Beneden.
IDSA has published more than 50 treatment guidelines on various conditions and infections, ranging from HIV/AIDS to Clostridium difficile. As with other IDSA guidelines, the Group A strep pharyngitis guidelines will be available in a smartphone format and a pocket-sized quick-reference edition. A podcast with the lead author and the full guidelines are available free on the IDSA website at www.idsociety.org.
Source: Infectious Diseases Society of America (IDSA)
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.
Global Patients, Local Risks: Why Medical Tourism Demands Infection Preventionists’ Attention
June 16th 2025At APIC25, infection prevention leader Heather Stoltzfus, MPH, RN, CIC, will spotlight the growing risks and overlooked responsibilities associated with medical tourism. Her session urges infection preventionists to engage with a global health trend that directly impacts US care settings.